1st Quarter - Report

THE NICKLES GROUP, LLC for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 515 / S. 610 / H.R. 1260, Patent Reform Act of 2009, all issues related to patent reform.

LobbyistCovered position, as disclosed
CYNTHIA MERIFIELD TRIPODI U.S. Senator Don Nickles, Legislative Assistant

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), S. 610 (111th), S. 515 (111th)

Medicare/Medicaid MMM

H.R. 3200, America's Affordable Health Choices Act, H.R. 3962, Affordable Health Care for America Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, and H.R. 4872, the Reconciliation Act of 2010, as they relate to Medicare and Medicaid pricing of prescription drugs.

LobbyistCovered position, as disclosed
DOUG BADGER Deputy Assistant to the President for Leg. Affairs
STACEY HUGHES U.S. Senate Budget Committee, Dpty. Staff Dir.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4872 (111th), H.R. 3962 (111th), H.R. 3590 (111th), H.R. 3200 (111th)

Taxation/Internal Revenue Code TAX

Issues relating to the taxation of foreign earnings of US multinational corporations. H.R. 3200, America's Affordable Health Choices Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, H.R. 3962, Affordable Health Care for America Act, H.R. 4872, the Reconciliation Act of 2010, and issues related to the taxation of pharmaceuticals. H.R. 4213, The Tax Extenders Act, as it relates to the research and development tax credit.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER U.S. Senate Budget Committee, Tax Policy Dir.
HAZEN MARSHALL U.S. Senate Budget Committee, Staff Director
DON NICKLES U.S. Senator

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th), H.R. 3962 (111th), H.R. 4213 (111th), H.R. 3200 (111th), H.R. 4872 (111th)

Health Issues HCR

H.R. 1427 / S. 726, Promoting Innovation & Access to Life Saving Medicine Act; H.R. 1548, Pathway for Biosimilars Act as it relates to FDA approval of follow on biologics; H.R. 3200, America's Affordable Health Choices Act, H.R. 3962, Affordable Health Care for America Act, H.R. 3590, The Patient Protection & Affordable Health Care Act, and H.R. 4872, the Reconciliation Act of 2010, as they relate to the Sunshine Act; drug pricing; and drug reimportation.

LobbyistCovered position, as disclosed
DOUG BADGER Deputy Assistant to the President for Leg. Affairs
STACEY HUGHES U.S. Senate Budget Committee, Dpty. Staff Dir.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th), H.R. 3200 (111th), H.R. 1548 (111th), H.R. 1427 (111th), S. 726 (111th), H.R. 3962 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.